SEARCH

SEARCH BY CITATION

References

  • Bowman RJ, Faal H, Jatta B et al. (2002) Longitudinal study of trachomatous trichiasis in The Gambia: barriers to acceptance of surgery. Investigative Ophthalmology & Visual Science 43, 936940.
  • Gebre T, Ayele B, Zerihun M et al. (In press) A cluster-randomized clinical trial comparing annual to twice-yearly azithromycin treatment for hyperendemic infectious trachoma in Ethiopia. Lancet.
  • House JI, Ayele B, Porco TC et al. (2009) Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial. Lancet 373, 11111118.
  • Keenan JD, Ayele B, Moncada J et al. (2011) RibosomalRNA evidence of ocular Chlamydia trachomatis infection following three annual mass azithromycin distributions in communities with highly prevalent trachoma. Clinical Infectious Diseases. Epub ahead of print. DOI: 10.1167/iovs.11-8493. (accessed 08 February 2012).
  • Melese M, Chidambaram JD, Alemayehu W et al. (2004) Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 292, 721725.
  • Nakibinge S, Maher D, Katende J, Kamali A, Grosskurth H & Seeley J (2009) Community engagement in health research: two decades of experience from a research project on HIV in rural Uganda. Tropical Medicine and International Health 14, 190195.
  • Oliva MS, Munoz B, Lynch M, Mkocha H & West SK (1997) Evaluation of barriers to surgical compliance in the treatment of trichiasis. International Ophthalmology 21, 235241.
  • Oyejide CO & Fagbami AH (1988) An epidemiological study of rotavirus diarrhoea in a cohort of Nigerian infants: I. Methodology and experiences in the recruitment and follow-up of patients. International Journal of Epidemiology 17, 903907.
  • Porco TC, Gebre T, Ayele B et al. (2009) Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 302, 962968.
  • Rabiu MM & Abiose A (2001) Magnitude of trachoma and barriers to uptake of lid surgery in a rural community of northern Nigeria. Ophthalmic Epidemiology 8, 181190.
  • Ray KJ, Porco TC, Hong KC et al. (2007) A rationale for continuing mass antibiotic distributions for trachoma. BMC Infectious Diseases 7, 91.
  • Shah NA, House J, Lakew T et al. (2010) Travel and implications for the elimination of trachoma in ethiopia. Ophthalmic Epidemiology 17, 113117.
  • Solomon A, Zondervan M, Kuper H, Buchan J, Mabey D & Foster A (2006) Trachoma Control: A Guide for Programme Managers. World Health Organization, Geneva.
  • Thylefors B, Dawson CR, Jones BR, West SK & Taylor HR (1987) A simple system for the assessment of trachoma and its complications. Bulletin of the World Health Organization 65, 477483.
  • West SK, Munoz B, Mkocha H, Gaydos C & Quinn T (2007) Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. Investigative Ophthalmology & Visual Science 48, 14921497.
  • Wright HR, Turner A & Taylor HR (2008) Trachoma. Lancet 371, 19451954.
  • Wright HR, Keeffe JE & Taylor HR (2010) Barriers to the implementation of the SAFE strategy to combat hyperendemic trachoma in Australia. Ophthalmic Epidemiology 17, 349359.
  • Yang JL, Schachter J, Moncada J et al. (2007) Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma. The British Journal of Ophthalmology 91, 293295.
  • Yang JL, Hong KC, Schachter J et al. (2009) Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification. Investigative Ophthalmology & Visual Science 50, 9094.